Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-04-11 Purchase |
2024-04-15 06:04 am |
Oncocyte Corp | OCX | Riggs Josh CEO and President |
3,390 | $2.95 | $10,001 | 3,505 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-26 Option Award |
2025-03-28 4:05 pm |
N/A N/A |
Oncocyte Corp | OCX | Riggs Josh CEO and President |
188,679 | $0 | 188,679 (Direct) |
View |
| 2024-05-20 Option Award |
2024-05-22 4:56 pm |
N/A 2034-05-20 |
Oncocyte Corp | OCX | Riggs Josh CEO and President |
90,000 | $0 | 90,000 (Direct) |
View |
| 2023-08-15 Option Award |
2023-08-17 6:57 pm |
N/A 2033-08-15 |
Oncocyte Corp | OCX | Riggs Josh CEO and President |
40,000 | $0 | 40,000 (Direct) |
View |
| 2023-06-09 Option Award |
2023-06-13 4:05 pm |
N/A 2033-06-09 |
Oncocyte Corp | OCX | Riggs Josh CEO and President |
1,150,000 | $0 | 1,150,000 (Direct) |
View |
| 2023-02-24 Option Award |
2023-02-28 5:59 pm |
N/A 2033-02-24 |
Oncocyte Corp | OCX | Riggs Josh CEO |
116,426 | $0 | 116,426 (Direct) |
View |
| 2023-01-17 Option Award |
2023-01-19 5:18 pm |
N/A 2033-01-17 |
Oncocyte Corp | OCX | Riggs Josh Interim CEO |
257,485 | $0 | 257,485 (Direct) |
View |
Ownership |
2022-12-09 8:19 pm |
N/A N/A |
Oncocyte Corp | OCX | Riggs Josh Interim CEO |
0 | $0 | 467,320 (Direct) |
View |